Related Experiment Videos
[Severe Graves' acropachy and dermopathy. Three case reports].
E Proust-Lemoine1, M C Vantyghem, C Bauters
1Clinique endocrinologique Marc Linquette, CHU de Lille.
Presse Medicale (Paris, France : 1983)
|April 30, 2005
Summary
Severe Graves' disease can present with difficult-to-diagnose acropachy and myxedema. Bone scintigraphy aids early diagnosis, but no permanent cure exists for these Graves' disease complications.
Area of Science:
- Endocrinology
- Rheumatology
Background:
- Severe Graves' disease can manifest with acropachy and tibial myxedema, which are rare and challenging to diagnose.
- Delayed diagnosis of these extra-thyroidal manifestations can impede timely treatment initiation.
Observation:
- Presents three cases of patients with severe ophthalmopathy, pretibial myxedema, and acropachy.
- Highlights the varied clinical presentations of these advanced Graves' disease symptoms.
Findings:
- Bone scintigraphy is a valuable tool for the early diagnosis of acropachy, complementing traditional methods like biopsies and X-rays.
- Disease severity, hypothyroidism episodes, and smoking are key factors in developing these extra-thyroidal manifestations.
- Currently, no definitive treatment effectively resolves the functional and aesthetic issues associated with Graves' dermopathy and acropachy.
Implications:
- Emphasizes the importance of advanced diagnostic techniques like bone scintigraphy for prompt identification of acropachy.
- Underscores the multifactorial nature of Graves' disease complications, involving disease activity, thyroid status, and lifestyle factors.
- Highlights the unmet need for effective therapeutic strategies for the long-term management of Graves' acropachy and dermopathy.